Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice
Oncotarget
Saved in:
Main Authors: | Guo, K., Tang, J.P., Jie, L., Al-Aidaroos, A.Q.O., Hong, C.W., Tan, C.P.B., Park, J.E., Varghese, L., Feng, Z., Zhou, J., Chng, W.J., Zeng, Q. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/115091 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
by: Guo, Ke, et al.
Published: (2021) -
Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia
by: Park, J.E., et al.
Published: (2014) -
PRL-3 phosphatase and cancer metastasis
by: Al-Aidaroos, A.Q.O., et al.
Published: (2014) -
Development of Biological Therapeutic Agents
by: Wanpen Chaicumpa
Published: (2021) -
PRL-3 promotes epithelial-mesenchymal transition and confers resistance to apoptosis
by: SAMANTHA QUAH YILING
Published: (2010)